SecBot SecBot
DEFA14A ·Filed Jul 2, 2026

BBLG

Bone Biologics Corp
NEUTRAL
Impact 3/10
Horizondays Processed3mo ago SEC0001493152-26-031653
Proxy solicitation materials
Actionable Insight • Neutral

Monitor for the definitive proxy statement (DEF 14A) to understand the specific proposals being voted on. The DEFA14A filing indicates active solicitation, but without document content, no actionable trading signal can be derived.

DirectionNeutral
Confidencelow
Horizondays
Final — all horizons settled through T+60d
BBLG ▼ -65.41% at T+60d
NEUTRAL call -65.41% · α vs SPY -68.42% · entry $1.42 → $0.4912
Entry = T+0 close
Jul 2, 2026
via day close
T+1d
+1.41%
call +1.41% · α +0.54%
$1.44
settled 4mo ago
T+5d
-2.82%
call -2.82% · α -3.75%
$1.38
settled 4mo ago
T+20d
-39.43%
call -39.43% · α -39.01%
$0.8601
settled 3mo ago
T+60d
-65.41%
call -65.41% · α -68.42%
$0.4912
settled 4w ago

Price Chart

Loading chart...

Executive Summary

Bone Biologics Corp filed a DEFA14A (additional definitive proxy soliciting materials) on July 2, 2026. The filing is a management proxy solicitation, but the actual document content is unavailable — only the SEC header and filing metadata are provided. The filing type suggests ongoing shareholder voting or solicitation activity, but no specific proposals, financial data, or activist demands can be extracted from the available documents.

Key Facts

  • Filed DEFA14A on July 2, 2026 — additional definitive proxy soliciting materials
  • Filed by Bone Biologics Corp (registrant) — management proxy solicitation
  • Document content is unavailable; only SEC header and metadata provided
  • Market cap is approximately $3M with 86% bullish analyst consensus

Financial Impact

No financial data available in filing documents

Risk Factors

  • Document content unavailable — analysis based solely on filing metadata
  • Micro-cap stock ($3M market cap) with limited liquidity and high volatility

Market Snapshot

Exchange
Nasdaq
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001493152-26-031653
Document: 0001493152-26-031653-index-headers.html0001493152-26-031653
Document: 0001493152-26-031653-index.html0001493152-26-031653
Document: 0001493152-26-031653.txt0001493152-26-031653
6 reports for BBLG
Performance horizon
100% Hit rate @ T+60 3 of 3 directional calls Went positive at some point 3 of 3 best @ T+60▲ +65.55%Jul 8, 2026
Filters
Rows
Reports for BBLG — sortable, filterable
TypeNow
Oct 13, 2026
14d ago
25-NSE
NEUTRAL ★ 3/10
$0.4300awaiting T+60—$0.3680 (−14.42%)
Jul 27, 2026
13w ago
EFFECT
BEARISH ★ 8/10
$1.03 $0.4105▲ +59.95%▲ +63.66%$0.3680 (+64.10%)
Jul 20, 2026
14w ago
DEFA14A
NEUTRAL ★ 3/10
$1.11 $0.4300▼ −61.26%▼ −65.23%$0.3680 (−66.85%)
Jul 17, 2026
14w ago
S-3
BEARISH ★ 8/10
$1.12 $0.4300▲ +61.61%▲ +66.45%$0.3680 (+67.14%)
Jul 8, 2026
16w ago
Press Release
BEARISH ★ 7/10
$1.38 $0.4754▲ +65.55%▲ +67.94%$0.3680 (+73.33%)
Jul 2, 2026
16w ago
DEFA14A
NEUTRAL ★ 3/10
$1.42 $0.4912▼ −65.41%▼ −68.42%$0.3680 (−74.08%)
Showing 6 of 6

US Market Status

Market Closed — Opens in 8h 24m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 2, 2026